This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Apo-Naproxen Tablets (2014-02-18)

Starting date:
February 18, 2014
Posting date:
February 25, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-38071

Recalled Products

  1. Apo-Naproxen Tablets

Reason

Lots may contain a foreign material embedded in tablets originating from silicone tubing (which comes into product contact) used during manufacturing.

Depth of distribution

Wholesalers/distributors and retailers in Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Northwest Territories, Ontario, Prince Edward Island, Quebec and Saskatchewan

Affected products

A. Apo-Naproxen Tablets

DIN, NPN, DIN-HIM
DIN 00522651
Dosage form

Tablet

Strength
  • 250 mg
Lot or serial number
  • KJ3191
  • KJ3194
Companies
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA

Date modified: